Newsfeeds - Spark Newswire

1 minute read

MediciNova To Test Ibudilast In BARDA’s Validated Mouse Model Of Chlorine-Induced Pulmonary Injury

Today, 6:16 PM

MediciNova Inc (NASDAQ:MNOV) will conduct a mouse study to investigate the efficacy of MN-166 (ibudilast) in a murine model of chlorine-induced…

MNOV

1 minute read

News

MediciNova To Conduct Mouse Study Under Partnership With BARDA To Develop MN-166 As A Medical Countermeasure Against Chlorine Gas-induced Lung Injury

By Benzinga Newsdesk

Today, 6:16 PM

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it will conduct a mouse study to

MNOV

1 minute read

MediciNov Sees Volume After Zacks Research Raises Price Target To $28

By Vandana Singh

Today, 6:16 PM

MediciNov Inc (NASDAQ: MNOV) sees a trading volume of 18.5 million shares after Zacks Small Cap Research increased the stock price target to $28 from $26.5 earlier.

MNOV

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 6:16 PM

APVO

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 6:16 PM

ADIL

2 minute read

21 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 6:16 PM

Gainers Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) rose 29.2% to $3.71 in pre-market trading as traders circulated an article titled "Revisiting Adial Pharmaceuticals: EMA Approval For Alcohol Use Disorder Pill Is A Critical Catalyst."

ADIL

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:16 PM

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.

AEI